Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells

Clinical and Experimental Immunology

Volumn 161, Issue 2, 2010, Pages 357-363

  Li, F R ^a   Wang, X G ^a   Deng, C Y ^a   Qi, H ^a   Ren, L L ^a   Zhou, H X ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

dendritic cell; immune modulation; islet transplantation; mesenchymal stem cell; T lymphocyte subsets

Indexed keywords

INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; C57BL MOUSE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; ENDOCYTOSIS; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEMORY T LYMPHOCYTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD11C; ANTIGENS, CD45; ANTIGENS, CD86; BLOOD GLUCOSE; BONE MARROW CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; DEXTRANS; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOGLOBULINS; IMMUNOMODULATION; INTERLEUKIN-12; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY; LYMPHOCYTE COUNT; MALE; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHAGOCYTOSIS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS;

EID: 77954641328     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04178.x     Document Type: Article

References (32)

1. Ichii H, Ricordi C. Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg 2009 16 : 101 12.
2. Keating A. How do mesenchymal stromal cells suppress T cells? Cell Stem Cell 2008 2 : 106 8.
3. Jones S, Horwood N, Cope A, Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 2007 179 : 2824 31.
4. Li H, Guo Z, Jiang X, Zhu H, Li X, Mao N. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 2008 26 : 2531 41.
5. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004 103 : 1662 8.
6. Li FR, Qiu L, Yang XF, Qi H, Ren LL, Zhou HX. The protective effects of ulinastatin and adenosine triphosphate on islet function during islet isolation and after islet transplantation. Pancreas 2009 38 : 227 30.
7. Figliuzzi M, Cornolti R, Perico N et al. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc 2009 41 : 1797 800.
8. Solari MG, Srinivasan S, Boumaza I et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J Autoimmun 2009 32 : 116 24.
9. Aksu AE, Horibe E, Sacks J et al. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats. Clin Immunol 2008 127 : 348 58.
10. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105 : 1815 22.
11. Boumaza I, Srinivasan S, Witt WT et al. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 2009 32 : 33 42.
12. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006 98 : 1076 84.
13. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99 : 3838 43.
14. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004 103 : 4619 21.
15. Zhang B, Liu R, Shi D et al. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 2009 113 : 46 57.
16. Lim JY, Min BH, Kim BG et al. Combinations of growth factors enhance the potency of islets in vitro. Pancreas 2009 38 : 447 53.
17. Vasavada RC, Gonzalez-Pertusa JA, Fujinaka Y, Fiaschi-Taesch N, Cozar-Castellano I, Garcia-Ocana A. Growth factors and beta cell replication. Int J Biochem Cell Biol 2006 38 : 931 50.
18. Suarez-Pinzon WL, Lakey JR, Brand SJ, Rabinovitch A. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass. J Clin Endocrinol Metab 2005 90 : 3401 9.
19. Itakura S, Asari S, Rawson J et al. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant 2007 7 : 336 46.
20. Rainsford E, Reen DJ. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol 2002 116 : 702 9.
21. Dutt S, Tseng D, Ermann J et al. Naive and memory T cells induce different types of graft-versus-host disease. J Immunol 2007 179 : 6547 54.
22. Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003 101 : 3722 9.
23. Mazo IB, Honczarenko M, Leung H et al. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity 2005 22 : 259 70.
24. Lutz MB, Kurts C. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur J Immunol 2009 39 : 2325 30.
25. Jung YJ, Ju SY, Yoo ES et al. MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DC. Cytotherapy 2007 9 : 451 8.
26. Ramasamy R, Fazekasova H, Lam EW, Soeiro I, Lombardi G, Dazzi F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007 83 : 71 6.
27. Chen L, Zhang W, Yue H et al. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev 2007 16 : 719 31.
28. Beyth S, Borovsky Z, Mevorach D et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005 105 : 2214 19.
29. English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 2008 115 : 50 8.
30. Van Parijs L, Perez VL, Biuckians A, Maki RG, London CA, Abbas AK. Role of interleukin 12 and costimulators in T cell anergy in vivo. J Exp Med 1997 86 : 1119 28.
31. Deng S, Moore DJ, Huang X et al. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol 2007 178 : 6028 32.
32. Visser L, Poppema S, de Haan B et al. Prolonged survival of rat islet xenografts in mice after CD45RB monotherapy. Transplantation 2004 77 : 386 91.